Compare CMMB & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMMB | BTTC |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | Israel | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 13.4M |
| IPO Year | 2023 | N/A |
| Metric | CMMB | BTTC |
|---|---|---|
| Price | $1.60 | $1.11 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 38.5K | 20.9K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $39.00 | ★ $2.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $1.10 |
| 52 Week High | $3.86 | $11.22 |
| Indicator | CMMB | BTTC |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 31.92 |
| Support Level | $1.44 | N/A |
| Resistance Level | $1.89 | $1.41 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 42.55 | 14.07 |
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.